IP Library Assignment 064824/0596
Patent Assignment
Reel/Frame 064824/0596

Merger

Recorded: 2023-09-07 Pages: 14
Assignor
UNIVERSITE DE NANTES
Executed: 2021-10-01
Assignee
NANTES UNIVERSITE
1 QUAI DE TOURVILLE, BP 13522, NANTES CEDEX 1, 44035, FRANCE
Covered Properties (91)
Efficient Systemic Treatment of Dystrophic Muscle Pathologies
Application: 17/000,867 →
Publication: US US20200405810A1
Methods and Compositions for Predicting Chronic Lung Allograft Dysfunction
Application: 16/331,792 →
Publication: US US20190226027A1
Methods and Compositions for Predicting Chronic Lung Allograft Dysfunction
Application: 17/196,853 →
Publication: US US20210404000A1
Efficient Systemic Treatment of Dystrophic Muscle Pathologies
Application: 15/321,416 →
Publication: US US20170157213A1
Efficient Systemic Treatment of Dystrophic Muscle Pathologies
Application: 16/185,248 →
Publication: US US20190167762A1
Methods and Compositions For Predicting Chronic Lung Allograft Dysfunction
Application: 16/624,061 →
Publication: US US20210139989A1
Chemical Functionalization of Cellulosic Materials with Diazo Compounds
Application: 17/926,341 →
Publication: US US20230183383A1
Methods for Reprogramming Cells
Application: 17/776,506 →
Publication: US US20220389376A1
New Vaccinal Strategy
Application: 17/046,816 →
Publication: US US20210154282A1
Lithium-Sulfur Battery
Application: 15/125,457 →
Publication: US US20180175375A1
Lithium-Sulphur Battery
Application: 15/322,714 →
Publication: US US20170141397A1
Organic Lithium Battery
Application: 15/529,328 →
Publication: US US20170271677A1
Strain Measuring Device
Application: 14/775,506 →
Publication: US US20160202133A1
Process for Diagnosing Chronic Inflammatory Intestinal Diseases
Application: 16/085,993 →
Publication: US US20200311910A1
Use of Lacunar Spinels with Tetrahedral Aggregates of a Transition Element of the AM4X8 Type with an Electronic Data Rewritable Non Volatile Memory, and Corresponding Material
Patent: 8,305,794 →
Application: 12/526,984 →
Publication: US US20100133494A1
Gallium-doped phosphocalcic compounds
Patent: 8,623,311 →
Application: 12/716,862 →
Publication: US US20100269734A1
Novel Melanoma Antigen Peptide and Uses Thereof
Patent: 8,604,166 →
Application: 13/060,484 →
Publication: US US20110212098A1
High-Energy Non-Aqueous Batteries Containing Ion-Conducting Gels, and Method for Preparing and Using Same
Patent: 8,915,975 →
Application: 13/148,401 →
Publication: US US20120021279A1
Novel Melanoma Antigen Peptide and Uses Thereof
Patent: 8,975,371 →
Application: 14/086,067 →
Publication: US US20140088290A1
Multimeric Mannosides, a Process for Preparing the Same and Their Uses as a Drug
Application: 14/416,529 →
Publication: US US20150210781A1
Microstructured Substrate
Application: 15/027,065 →
Publication: US US20160240882A1
Method for Determining a Visual Quality Index of a High Dynamic Range Video Sequence
Patent: 9,794,554 →
Application: 15/087,578 →
Publication: US US20170289539A1
Single-Component Artificial Neuron Based on Mott Insulators, Network of Artificial Neurons and Corresponding Manufacturing Method
Application: 15/307,269 →
Publication: US US20170124449A1
Photo-Crosslinkable Emissive Molecular Materials
Application: 15/552,336 →
Publication: US US20180030342A1
Tungstate Ion Solution and Hybrid Photovoltaic Device
Application: 16/069,389 →
Publication: US US20190019953A1
Method for the Culture of Photosynthetic Organisms Using a CO2 Source
Application: 16/075,943 →
Publication: US US20200263120A1
Optical Fibre Curvature Sensor and Measurement Device Comprising Said Sensor
Application: 16/087,290 →
Publication: US US20200240771A1
Use of a Battery with Polyviologen Active Material
Application: 16/678,884 →
Publication: US US20200152984A1
Method for Synthesizing Iodo- or Astatoarenes Using Diaryliodonium Salts
Application: 16/844,077 →
Publication: US US20200239404A1
Diagnosis, Prognosis and Treatment of a Disease Related to a Decrease of F. Prausnitzii
Application: 17/059,315 →
Publication: US US20210215676A1
Modified Phosphocalcic Compound, Injectable Composition Containing Same
Patent: 7,521,436 →
Application: 10/506,550 →
Publication: US US20050282783A1
Macroporous, Resorbable and Injectible Calcium Phosphate-Based Cements (Mcpc) for Bone Repair, Augmentation, Regeneration, and Osteoporosis Treatment
Patent: 7,351,280 →
Application: 11/054,623 →
Publication: US US20050199156A1
Modified Phosphocalcic Compound, Injectable Composition Containing Same
Patent: 8,044,037 →
Application: 12/385,614 →
Publication: US US20090203648A1
Use of Monoclonal Antibodies Specific to the O-Acetylated Form of GD2 Ganglioside for Treatment of Certain Cancers
Patent: 8,951,524 →
Application: 12/445,071 →
Publication: US US20100150910A1
Silylated Biomolecules
Patent: 9,285,360 →
Application: 13/574,970 →
Publication: US US20130004460A1
Cytological Method Using the Auto Fluorescence of White Corpuscles for the Early Diagnosis and the Monitoring of Infections
Patent: 9,709,501 →
Application: 14/006,455 →
Publication: US US20150037837A1
Gallium-doped phosphocalcic compounds
Patent: 8,920,555 →
Application: 14/094,314 →
Publication: US US20140087004A1
Magnetic and Fluorescent Reverse Nanoassemblies
Patent: 9,597,418 →
Application: 14/218,368 →
Publication: US US20150265728A1
Use of Centrosymmetric Mott Insulators in a Resistive Switched Memory for Storing Data
Patent: 9,837,607 →
Application: 14/391,994 →
Publication: US US20150255714A1
Sanding Device Including Means for Changing a Sanding Disk
Patent: 9,969,052 →
Application: 14/651,049 →
Publication: US US20160039067A1
Bandage Containing Foetal Fibroblasts and Keratinocytes
Application: 14/651,887 →
Publication: US US20150320804A1
Device and Method for Electrochemically Synthesizing Intermediate Species of a Chemical Entity
Application: 14/759,344 →
Publication: US US20160053389A1
Use of a Genetically Modified Infectious Measles Virus with Enhanced Pro-Apoptotic Properties (Mv-Deltac Virus) in Cancer Therapy
Patent: 9,889,193 →
Application: 14/762,559 →
Publication: US US20150359873A1
Modulators of Intracellular Chloride Concentration for Treating Neurodegenerative Diseases with Parkinsonian Syndromes
Patent: 9,974,763 →
Application: 14/894,621 →
Publication: US US20160106693A1
RAC1 Inhibitors for Inducing Bronchodilation
Application: 14/897,970 →
Publication: US US20160120872A1
Method for Determining Characteristics of Holes to Be Provided Through a Plate and Corresponding Programme
Application: 14/914,900 →
Publication: US US20160210391A1
Orally Available Compounds, a Process for Preparing the Same and Their Uses as Anti-Adhesive Drugs for Treating E. Coli Induced Inflammatory Bowel Diseases Such as Crohn's Disease
Application: 15/113,986 →
Publication: US US20160340445A1
Methods for Determining Whether a Patient Will Achieve a Response After Radiation Therapy
Application: 15/313,338 →
Publication: US US20170184566A1
A Method for Inhibiting or Reducing Transplant Rejection by Adminstration of Interleukin-34
Application: 15/326,515 →
Publication: US US20170202921A1
Degumming Method
Application: 15/518,926 →
Publication: US US20170233499A1
Method and Device for Measuring Path Following Under Load
Application: 15/532,494 →
Publication: US US20180038748A1
Anti Il-34 Antibodies
Application: 15/536,962 →
Publication: US US20170342148A1
Use of a Laminin for Differentiating Pluripotent Cells into Hepatocyte Lineage Cells
Application: 15/551,551 →
Publication: US US20180030415A1
New Method for Treating and Prognosing Cancer
Application: 15/554,599 →
Publication: US US20180238885A1
Methods and Kits for Labeling, Detection and Isolation of FOXP3+ Regulatory T Cells, Isolated Population of FOXP3+ Regulatory T Cells Thus Obtained and Uses Thereof
Application: 15/573,068 →
Publication: US US20180106779A1
Methods for Obtaining Regulatory T Cells and Uses Thereof
Application: 15/740,997 →
Publication: US US20180187151A1
System for Assessing Chloride Concentration and Corresponding Method and Sensor
Application: 15/743,053 →
Publication: US US20190107525A1
Mannose Derivatives Useful for Treating Pathologies Associated with Adherent E. Coli
Application: 15/750,471 →
Publication: US US20180235991A1
An Anti-Metastatic Marine Bacterial Exopolysaccharide Derivative and Uses Thereof
Application: 15/763,407 →
Publication: US US20180280427A1
Method for Synthesizing Iodo- or Astatoarenes Using Diaryliodonium Salts
Application: 15/777,828 →
Publication: US US20190023646A1
Use of a Genetically Modified Infectious Measles Virus with Enhanced Pro-Apoptotic Properties (Mv-Deltac Virus) in Cancer Therapy
Application: 15/880,133 →
Publication: US US20180221469A1
Hybrid Dual Recombinant Aav Vector Systems for Gene Therapy
Application: 16/065,145 →
Publication: US US20190002916A1
A Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
Application: 16/174,837 →
Publication: US US20190060405A1
Methods for Promoting T Cells Response by Administering an Antagonist of Human C-Type Lectin-Like Receptor 1 (Clec-1)
Application: 16/343,757 →
Publication: US US20190309075A1
Use of a Genetically Modified Infectious Measles Virus with Enhanced Pro-Apoptotic Properties (Mv-Deltac Virus) in Cancer Therapy
Application: 16/429,571 →
Publication: US US20200016260A1
Multivalent Fucose Derivatives for Use as a Drug
Application: 16/485,899 →
Publication: US US20200268782A1
Orally Available Compounds, a Process for Preparing the Same and Their Uses as Anti-Adhesive Drugs for Treating E. Coli Induced Inflammatory Bowel Diseases Such as Crohn's Disease
Application: 16/548,704 →
Publication: US US20190374559A1
CD24HICD38HI Transitional B Cells and CD9 as New Biomarker of Long-Term Human Lung Allograft Survivial
Application: 16/607,762 →
Publication: US US20200057064A1
Diagnosis, Prevention and Treatment of Demyelinating Disorders of the Central Nervous System
Application: 16/611,704 →
Publication: US US20210138001A1
Inhibitors of RAC1 and Uses Thereof for Treating Cancers
Application: 16/619,311 →
Publication: US US20200095199A1
Inhibitors of RAC1 and Uses Thereof for Inducing Bronchodilatation
Application: 16/620,237 →
Publication: US US20210077508A1
Interleukin 12 (IL12) or Derivative Thereof for Use in the Treatment of Secondary Disease
Application: 16/631,687 →
Publication: US US20200147177A1
Methods and Compositions for Predicting and Treating Intracranial Aneurysm
Application: 16/758,458 →
Publication: US US20200256879A1
Methods for Obtaining Regulatory T Cells and Uses Thereof
Application: 16/899,142 →
Publication: US US20200308543A1
Novel Method for Obtaining T Cells from Pluripotent Stem Cells, and Uses Thereof
Application: 16/982,881 →
Publication: US US20210002612A1
Methods and Compositions for Treating Asthma and Allergic Diseases
Application: 17/273,082 →
Publication: US US20210278420A1
Anti-Human CD45RC Antibodies and Uses Thereof
Application: 17/277,511 →
Publication: US US20220033500A1
Algal Extract for Use in the Treatment or Prevention of Post-Traumatic Immunosuppression
Application: 17/286,999 →
Publication: US US20210386808A1
Disulfonate Stilbenes for Use in the Treatment of Proliferative Diseases
Application: 17/295,231 →
Publication: US US20220016068A1
Method for Locating and Characterizing Bifurcations of a Cerebral Vascular Tree, Associated Methods and Devices
Application: 17/299,481 →
Publication: US US20220067928A1
Isolated Mhc-Derived Human Peptides and Uses Thereof for Stimulating and Activating the Suppressive Function of CD8+CD45RCLOW Tregs
Application: 17/312,161 →
Publication: US US20220064260A1
Isolated Interleukin-34 Polypeptide for Use in Preventing Transplant Rejection and Treating Autoimmune Diseases
Application: 17/371,646 →
Publication: US US20210401940A1
Methods and Kits for Generating and Selecting a Variant of a Binding Protein with Increased Binding Affinity and/or Specificity
Application: 17/421,175 →
Publication: US US20220106584A1
In Vitro Method for Determining the Likelihood of Occurrence of an Acute Microvascular Rejection (Amvr) Against a Renal Allograft in an Individual
Application: 17/421,987 →
Publication: US US20220404356A1
Inhibitor of Surface Protein (Sp-D) / Sirpa / SHP2 Pathway for Use in the Prevention and/or Treatment of Secondary Infection
Application: 17/596,958 →
Publication: US US20220227849A1
Use of Proteins Pd-1 and CD38 as Markers of an Active Auto-Immune Pathology
Application: 17/608,908 →
Publication: US US20220317120A1
Method of Promoting a T-Cell Response or Treating Cancer by Administering an Antagonist to Human C-Type Lectin-Like Receptor-1 (Clec-1)
Application: 17/740,849 →
Publication: US US20220281983A1
Method for Preparing a Conductive, Transparent and Flexible Membrane
Application: 16/615,387 →
Publication: US US20200157674A1
Method for Preparing a Conductive, Transparent and Flexible Membrane
Application: 17/669,850 →
Publication: US US20220162736A1
Method, System and Software Program for Shooting and Editing a Film Comprising at Least One Image of a 3D Computer-Generated Animation
Patent: 9,367,942 →
Application: 13/688,844 →
Publication: US US20130135315A1
Method for Preparing an Elastomer from a Hydroxylated Fatty Acid and Elastomer Obtained by Such a Method
Application: 17/622,509 →
Publication: US US20220251289A1
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 3, 2011
From: LABARRIERE, NATHALIE; MOREAU-AUBRY, AGNES; GODET, YANN
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE NANTES; CHU NANTES
Reel/Frame 026215/0973 →
Assignment of Assignor's Interest Oct 5, 2011
From: BUJOLI, BRUNO
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S)
Reel/Frame 027017/0631 →
Assignment of Assignor's Interest Oct 5, 2011
From: BOULER, JEAN-MICHEL; JANVIER, PASCAL
To: UNIVERSITE DE NANTES
Reel/Frame 027017/0564 →
Assignment of Assignor's Interest Oct 5, 2011
From: KHAIROUN, IBRAHIM; SCHNITZLER, VERENA
To: GRAFTYS
Reel/Frame 027017/0413 →
Assignment of Assignor's Interest Sep 14, 2015
From: FRANCOIS, MARC; LECIEUX, YANN; LEDUC, DOMINIQUE; LUPI, CYRIL
To: UNIVERSITE DE NANTES
Reel/Frame 036555/0721 →
Assignment of Assignor's Interest Jan 18, 2017
From: DICKSON, GEORGE; VOIT, THOMAS; MOULLIER, PHILIPPE; LE GUINER, CAROLINE
To: GENETHON; ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
Reel/Frame 041010/0652 →
Assignment of Assignor's Interest Feb 13, 2017
From: LECUYER, MARGAUD; DESCHAMPS, MARC; GAUBICHER, JOEL; LESTRIEZ, BERNARD
To: BLUE SOLUTIONS; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITE DE NANTES
Reel/Frame 041689/0372 →
Assignment of Assignor's Interest Nov 6, 2018
From: BRÉGEON, JÉRÉMY; NEUNLIST, MICHEL; CORON, EMMANUEL
To: UNIVERSITÉ DE NANTES; CHU DE NANTES - CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES; INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Reel/Frame 047423/0656 →
Assignment of Assignor's Interest Jun 12, 2019
From: ROYER, PIERRE-JOSEPH; MAGNAN, ANTOINE; BROUARD, SOPHIE; DANGER, RICHARD
To: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITÉ DE NANTES; CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
Reel/Frame 049443/0534 →
Assignment of Assignor's Interest Sep 26, 2019
From: GUYOMARD, DOMINIQUE; GAUBICHER, JOEL; LESTRIEZ, BERNARD; DESCHAMPS, MARC
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; BLUE SOLUTIONS; UNIVERSITE DE NANTES
Reel/Frame 050500/0062 →
Assignment of Assignor's Interest Dec 24, 2019
From: LECUYER, MARGAUD; DESCHAMPS, MARC; GAUBICHER, JOEL; POIZOT, PHILIPPE
To: BLUE SOLUTIONS; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITE DE NANTES
Reel/Frame 051416/0135 →
Assignment of Assignor's Interest Oct 27, 2020
From: LANG, FRANÇOIS; RABU, CATHERINE
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE NANTES
Reel/Frame 054175/0446 →
Assignment of Assignor's Interest Nov 30, 2021
From: GENETHON; ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
To: ASSOCIATION INSTITUT DE MYOLOGIE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; SORBONNE UNIVERSITE
Reel/Frame 058242/0262 →
Corrective Assignment to Correct the Address in the Sixth Assignee and Clearer Versions of Pages 3 and 12 Previously Recorded at Reel: 058242 Frame: 0262. Assignor(S) Hereby Confirms the Assignment. Mar 30, 2022
From: GENETHON; ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE
To: ASSOCIATION INSTITUT DE MYOLOGIE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; SORBONNE UNIVERSITE
Reel/Frame 059658/0764 →
Assignment of Assignor's Interest May 12, 2022
From: POLO, JOSE; LIU, XIAODONG; DAVIDSON, KATHRYN
To: MONASH UNIVERSITY
Reel/Frame 060047/0168 →
Assignment of Assignor's Interest May 12, 2022
From: DAVID, LAURENT; CASTEL, GAEL
To: UNIVERSITÉ DE NANTES
Reel/Frame 060981/0664 →
Assignment of Assignor's Interest May 12, 2022
From: RACKHAM, OWEN; OUYANG, JOHN F
To: NATIONAL UNIVERSITY OF SINGAPORE
Reel/Frame 060047/0411 →
Assignment of Assignor's Interest Jul 8, 2022
From: DANGER, RICHARD; BROUARD, SOPHIE; ROYER, PIERRE-JOSEPH; MAGNAN, ANTOINE
To: INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE NANTES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
Reel/Frame 060617/0375 →
Assignment of Assignor's Interest Feb 21, 2023
From: FELPIN, FRANÇOIS-XAVIER; BRETEL, GUILLAUME; LE GROGNEC, ERWAN; DENIS, MARIE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -; NANTES UNIVERSITE
Reel/Frame 062752/0479 →
Assignment of Assignor's Interest Aug 1, 2023
From: ROYER, PIERRE-JOSEPH; MAGNAN, ANTOINE; BROUARD, SOPHIE; DANGER, RICHARD
To: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITÉ DE NANTES; CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
Reel/Frame 064451/0092 →